Protai is an AI-powered drug discovery startup.
Protai has raised $12.0M in total funding. The most recent round was Seed. The last funding was announced in March 2023.
Protai's investors include Pitango VC, Maj Invest Equity, Grove Ventures.
Protai is headquartered in Tel Aviv, Israel.
Protai is an AI-powered drug discovery startup.
Protai is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Protai — Funding & Investors." VCBacked, March 15, 2023, https://www.vcbacked.co/company/protai. Accessed July 19, 2026.
VCBacked. (2023). Protai — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/protai
{{cite web |title=Protai — Funding & Investors |url=https://www.vcbacked.co/company/protai |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated